• Oncolytic Virus Research
  • Oncolytic Virus News
Creative Biolabs Oncolytic Virotherapy

Menu

Skip to content
  • Oncolytic Virus Research
  • Oncolytic Virus News

Monthly Archives: November 2020

18Nov/20

Global Oncolytic Virus Market and Listed Drugs

November 18, 2020Oncolytic Virus NewsOncolytic Virus, Oncolytic Virus Newsbiolabs

As early as around 1800, doctors discovered that certain cancer patients would have their symptoms eased after being briefly infected with some viruses. Although the concept of using viruses to treat cancerRead More…

18Nov/20

Strategies for Arming Oncolytic Viruses

November 18, 2020Oncolytic Virus ResearchOncolytic Virus, Oncolytic Virus Researchbiolabs

Oncolytic viruses have been proven to regulate the immune microenvironment, reduce suppressive immune phenotypes, and enhance anti-tumor immunity. Combining immune checkpoint inhibitors and oncolytic viruses is expected to overcome the resistance ofRead More…

Recent Posts

  • Combining Oncolytic Viruses with T-cell Therapy Enhances Cancer Treatment
  • Swine Pseudorabies Virus Attenuated Vaccine Shows Potential for Oncolytic Therapy Against Malignant Tumors
  • Oncolytic Virus Therapy CAN-3110 Shows Promise in Treating Aggressive Brain Cancer Glioblastoma
  • Research Reveals New Mechanism of Oncolytic Virus M1 Enhancing DC Vaccine’s Anti-Tumor Effect
  • Oncolytic Viruses Can Induce A “Cold” Tumor to Heat Up and Improve the Efficiency of Immunotherapy in Treating Cancer

Archives

  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • November 2020

Contact Us

USA – UK

Copyright © Creative Biolabs Oncolytic Virotherapy
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Oncolytic Virus Research
  • Oncolytic Virus News